The medical technology company Getinge has entered into an agreement to acquire the American company Paragonix Technologies, writes Getinge in a press release.
The total purchase price is estimated to be 477 million dollars, equivalent to approximately 4.9 billion kronor.
Paragonix Technologies is described as a leading company in products and services for organ transport.
"We look forward to entering this rapidly developing market, driven by a global shortage of organs and the urgent need to increase transplantation volume", says Elin Frostehav, responsible for Acute Care Therapies at Getinge, in a comment.
The acquisition is expected to "have a small impact on Getinge's adjusted earnings per share in 2024", writes the company.
